Purchase Order 75N93018P01184
Award Date 8/30/18
Potential Completion Date 9/23/18
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The federal contract award HHSN272201401000P was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the prime contractor Retrogenix LIMITED. The contract is for MICRO-ARRAY SERVICE and has a firm fixed price of $7,000.00. The period of performance runs from the award date of September 2, 2014 to the ultimate completion date of September 5, 2014. The contract does not have a set-aside designation. Retrogenix...
- Genscript USA Inc. was awarded a $54,900 firm-fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide customized antibody and plasmid preparation services. The award is associated with a pre-solicitation notice indicating the NIAID's intent to negotiate on a sole-source basis with Genscript for 100 customized antibodies and 200 plasmid preparations to support identification of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Quotient Biodiagnostics, Inc., a foreign-owned for-profit organization. The $1,281.00 firm-fixed-price order is for the ALBACYTE ANTIBODY SCREEN (3-CELL), which is described as specialized in vitro diagnostics and blood bank reagents. Quotient Biodiagnostics is a leading provider of these types of products and services, supporting blood banking operations across various federal agencies such as the...
- Retrogen, Inc. was awarded a $5,000 firm fixed-price purchase order on March 13, 2019, for retrogen DNA sequencing services with an ultimate completion date of September 30, 2019. The contract, issued by a civilian federal agency operating under the Pacific West Area, was awarded without a set-aside designation. Work is to be performed in Maricopa, Arizona, and the contract included additional funding through requisition 966702. The purchase order represents a direct procurement for...
- The Defense Health Agency awarded a $2.4 million firm fixed-price purchase order to Grifols Diagnostic Solutions Inc., the original equipment manufacturer and sole source provider, for annual dropshipment of FDA-approved Procleix reagents to support the United States Naval Hospital Okinawa in Japan. The contract, which extends through July 2, 2029, covers three specific test assays for the Procleix Panther nucleic acid testing analyzer: the Ultrio Elite assay, West Nile Virus assay, and...
- This is a firm-fixed-price purchase order contract awarded by the Defense Health Agency to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit subsidiary of the global healthcare company Grifols. The contract is for the provision of 1,000 ULTRIO ELITE test kits to support donor screening at the USNHO PACOM Armed Services Blood Bank Center. The contract has a ceiling value of $2,181,820.00 and a period of performance through July 15, 2024. This requirement was not set aside for any...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Retrogenix LIMITED for $7,000. The contract is for "other functions, service" and has a firm fixed-price structure. The period of performance runs from the award date of July 17, 2014 through October 15, 2014. This purchase order contract does not have a set-aside designation. Based on the information provided, this appears...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Quotient Biodiagnostics, Inc., a foreign-owned for-profit organization, for the provision of Albacyte antibody screening tests. The $1,281.00 contract has a completion date of March 26, 2024. Quotient Biodiagnostics is a supplier of in vitro diagnostics, including blood bank reagents, antibody screening tests, and quality control materials. The company has provided a range of biomedical goods and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $19,316.68 firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The contract is for the provision of custom plasmid preparation services to support biomedical research and public health initiatives. Genscript has extensive experience providing specialized products and services to federal...
- This is a delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The contract is for the supply of PANOCELL I, II, III (3X10ML) medical products, with a ceiling value of $153,884.39 and a period of performance through September 30, 2021. The contract was awarded on a firm fixed-price basis without any set-aside designation....
FOR OTHER FUNCTIONS RETROGENIX LTD. CUSTOMIZED PLASMA SAMPLE SCREEN
Posted 8/30/18
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Customized Plasma Sample Screens | NOI-RML-D-1922135 | Department of Health and Human Services National Institutes of Health | Solicitation 1/1 | 8/9/18, 5:57 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($634) | 10/15/21 | |
| Not listed | Not listed | $33.0k | 8/30/18 |